Fredrik Sjövall, Chairman
Appointed: April 5, 2017.
Qualifications: M.Sc. Automation Engineering, Master’s Degree in Business Development. (Non-independent Board member according to Spotlight regulations.)
Experience: Fredrik was previously CEO of Inhalation Sciences, responsible for the company’s successful listing in 2017. Fredrik has been Chairman of Inhalation Sciences since May 2018 and is Chairman of Monivent AB and Board member of Axelero AB and Lipidor AB.. Previously he served as Chairman of Hemcheck AB, listed on Nasdaq First North. Fredrik has also been CEO of PharmaSurgics AB and Lipopeptide AB (now merged with Promore pharma AB).
Current roles: Chairman of the Board of Inhalation Sciences, Board member of Axelero AB and Lipidor AB.
Appointed: May 18, 2018.
Qualifications: MBA with a Master’s Degree in Finance. (Independent Board member according to Spotlight regulations.)
Experience: Kristian has been an equity analyst at Remium Fondkommission and has been running his own investment company, Kristian Kierkegaard Holding AB, since 2011.
Current roles: Chairman of Kristian Kierkegaard Holding AB, Board member of AGOF Investments AB.
Appointed: 25 April 2018.
Qualifications: Qualified Pharmacist and Associate Professor in Pharmaceutical Sciences and Biopharmaceutics. (Independent Board member according to Spotlight regulations.)
Experience: Ola Camber has extensive experience in the pharmaceutical industry, including senior positions in formulation and drug delivery with, amongst others, Astra Zeneca. Ola is CEO of Camber Consulting AB, ClinStorage AB and ClinProducts AB.
Current roles: Board member of Camber Consulting AB, ClinStorage AB and ClinProducts AB
Appointed: 25 April 2018.
Qualifications: Bachelor of Business Administration, and Master’s Degree in Business Development from Chalmers School of Entrepreneurship. (Independent Board member according to Spotlight regulations.)
Experience: Mattias has worked with Product and Business Development in a range of pharmaceutical and medtech companies. He has been Chairman of Stayble Therapeutics AB, CEO of Acucort AB (listed on the stock market) and founder and Business Development manager at PharmaSurgics in Sweden AB (now ProMore Pharma AB, listed on First North).
Current roles: Currently he splits his time between VP Business Development Manager at Stayble Therapeutics AB and Life Science Business Coach at Chalmers Ventures AB.
Appointed: 20 Maj 2019.
Qualifications: MSc Molecular Biology (Independent Board member according to Spotlight regulations.)
Experience: Mikaela has 20 years of experience working at major global life-science companies. She has held several strategic commercial roles and senior management positions in the Nordic region, on global and HQ level. During 1999-2008, various commercial roles with MSD Sweden AB, 2008-2012 local marketing and strategic roles with AstraZeneca Sweden and Nordic-Baltic. From 2012 to 2015 she was the Global Head of Astra Zeneca’s Vaccine Franchise, from 2015-2019 Vice President of Nordic-Baltic Business Unit in Respiratory, Inflammation and Autoimmune disease (RIA). Since Aug 2019 Head of Nordic Region for Real World Evidence at IQVIA.